ArticleFrontiers in public health2025
Epidemiological intricacies of respiratory pathogens: a single-center study on infection dynamics in Beijing, 2023-2024.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The prevalence and role of human respiratory syncytial virus in pediatric respiratory tract infections: a systematic review and meta-analysis of global data.EClinicalMedicine · 2026Article
- Post-pandemic resurgence of Mycoplasma pneumoniae in coastal China: from seasonal waves to sustained transmission and expanded age susceptibility.BMC infectious diseases · 2026Article
- New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, andMicrobiology spectrum · 2026Article
- Pathogen profiles and co-detection characteristics of acute respiratory infections based on active surveillance in a large district of southern China.Frontiers in public health · 2026Article
- Time-series analysis of pollen concentration effects on allergic conjunctivitis healthcare visits in Beijing, 2023-2024.Frontiers in public health · 2026Article
- Epidemiological trends and climate-driven dynamics of children respiratory infections in Lanzhou, China: a multi-pathogen time-series analysis.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Following China's post-COVID-19 reopening strategy, intermittent small-scale outbreaks of respiratory pathogen infections have been observed in the Beijing region. This single-center study aims to characterize the epidemiological features and co-detection patterns of respiratory pathogens in Beijing, providing a scientific basis for the prevention and control of respiratory infectious diseases. Methods: We performed a retrospective analysis of 19,535 patients undergoing SARS-CoV-2 testing and 12,372 patients screened for six respiratory pathogens, including Results: SARS-CoV-2 positivity rate maintained above 3% throughout the observation period. IAV demonstrated distinct seasonal peaks in March 2023 (41.9%, 52/124), November-December 2023 (24.5%, 119/485 to 21.9%, 208/950), and December 2024 (25.4%, 289/1136). Poly-epidemics of multiple pathogens emerged between October 2023 and April 2024. Pediatric populations showed highest prevalence of MP (21.4%, 158/740), co-detection (15%, 111/740) and ADV (12.7%, 94/740), while adults predominantly exhibited SARS-CoV-2 (35.1%, 674/1920), RSV (15.8%, 304/1920) and IAV (12.3%, 236/1920). Among 324 co-detection cases, MP (130 cases), HRV (117 cases), and IAV (111 cases) were most frequently involved, with MP + HRV (36 cases), MP + IAV (31 cases), and HRV + IAV (23 cases) being the predominant pairwise combinations. Conclusion: Beijing experienced alternating waves of respiratory pathogen epidemics and co-detections during 2023-2024. IAV maintained characteristic winter-spring seasonality, while MP emerged as the predominant pathogen in co-detection events. Distinct pathogen profiles between pediatric and adult populations underscore the necessity for continuous surveillance and age-specific prevention strategies for respiratory infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.